Saturday 17 October 2026
Export STXS’s income statement to Excel — free account
Stereotaxis Inc.
STXS Healthcare Medical Instruments & Supplies
Stereotaxis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $32.4 million, up 20.3% from fiscal 2024. In the quarter to June 2026, revenue fell 12.8%, EPS was flat and free cash flow was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.01
0.04
−3.81%
Follow STXS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 5 | 2 | 4 | 3 | 2 | 3 | 3 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.47 | 0.61 | 1.92 | 11.54 | 13.90 | 13.38 | 5.67 | 5.64 | 7.22 | 6.46 |
Altman Z-Score |
(31.64) | (63.46) | (31.39) | (1.14) | 3.20 | 2.22 | (9.14) | (14.23) | (14.58) | (12.40) |
Altman Z″-Score (non-manufacturers) |
(80.87) | (162.69) | (81.40) | (30.74) | (22.09) | (22.06) | (28.80) | (41.04) | (41.73) | (37.21) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(2.63) | (3.28) | (1.65) | 1.32 | (3.20) | (0.91) | (3.52) | (3.97) | (3.53) | (1.95) |
P/Operating CF |
(115.91) | (23.66) | (72.38) | (174.17) | 1,202.59 | (384.30) | (62.59) | (61.88) | 153.41 | (52.71) |
P/B ratio |
0.00 | 0.00 | 42.90 | 14.65 | 10.70 | 13.85 | 6.06 | 9.23 | 31.94 | 15.52 |
Price to Tangible BV |
0.00 | 0.00 | 46.83 | 14.73 | 10.73 | 13.89 | 6.09 | 9.30 | 0.00 | 63.63 |
EV/Sales |
0.87 | 1.17 | 2.27 | 10.67 | 12.39 | 12.35 | 4.76 | 5.00 | 6.87 | 6.15 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(4.25) | (7.79) | (26.14) | (66.81) | (93.99) | (146.81) | (15.93) | (14.64) | (21.78) | (14.54) |
EV/FCF |
(3.94) | (7.66) | (23.67) | (66.39) | (91.78) | (99.59) | (12.42) | (14.08) | (21.69) | (14.44) |
Quick Ratio |
0.37 | 0.26 | 1.55 | 2.92 | 3.51 | 3.36 | 2.38 | 1.82 | 0.75 | 1.05 |
Current Ratio |
0.54 | 0.33 | 1.76 | 3.19 | 3.88 | 3.87 | 3.03 | 2.51 | 1.22 | 1.51 |
Net Debt/EBITDA |
1.50 | 0.73 | 5.83 | 5.97 | 6.56 | 3.07 | 1.57 | 0.94 | 0.52 | 0.65 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 4.79% | 1.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.07 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.61 | 1.97 | 2.01 | 0.93 | 0.54 | 0.60 | 0.49 | 0.56 | 0.61 | 0.65 |
Operating CF/Net income |
0.56 | 0.64 | 1.93 | 0.77 | 0.44 | 0.24 | 0.43 | 0.41 | 0.34 | 0.60 |
Capex/Depreciation |
(0.54) | (0.10) | (0.44) | (0.24) | (0.56) | (13.18) | (7.90) | (1.19) | (0.04) | (0.06) |
Interest Coverage |
(2.59) | (32.92) | (148.01) | (20.49) | (99.61) | — | (38.79) | — | — | — |
| 60.34% | 30.46% | 10.43% | (50.02%) | (27.94%) | (35.24%) | (65.26%) | (103.35%) | (226.13%) | (234.28%) | |
| (59.23%) | (46.28%) | (9.03%) | (19.39%) | (16.19%) | (20.72%) | (34.33%) | (46.28%) | (57.21%) | (46.30%) | |
ROIC |
0.00% | 0.00% | 0.00% | (698.34%) | 0.00% | (3,457.08%) | (394.59%) | (865.53%) | 0.00% | (260.75%) |
Return on Tangible Assets |
77.83% | 37.22% | (16.22%) | (22.37%) | (20.38%) | (29.59%) | (59.89%) | (94.56%) | (301.46%) | (157.94%) |
Average Days of Receivables |
52.95 | 50.25 | 62.45 | 67.31 | 48.18 | 56.34 | 66.01 | 52.11 | 51.85 | 114.57 |
Research and Development Expense of Revenue |
17.06% | 21.53% | 28.01% | 31.21% | 30.56% | 29.12% | 37.51% | 38.37% | 36.26% | 28.98% |
Selling, General and Administrative Expense of Revenue |
79.51% | 62.95% | 60.88% | 64.26% | 65.88% | 74.02% | 94.82% | 98.71% | 109.86% | 93.56% |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.20 |
Share Based Compensation of Revenue |
4.24% | 2.47% | 1.91% | 4.60% | 11.90% | 26.74% | 37.57% | 39.68% | 38.12% | 30.43% |
Graham Net Nets |
(1.12) | (1.13) | 0.12 | 0.07 | 0.10 | 0.06 | 0.14 | 0.09 | (0.05) | 0.00 |
Graham Number |
3.46 | 3.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(77.14%) | (41.67%) | (2.78%) | (1.70%) | (2.16%) | (2.58%) | (12.38%) | (14.97%) | (13.16%) | (10.87%) |
Free Cash Flow Yield |
(46.34%) | (25.04%) | (5.00%) | (1.39%) | (0.97%) | (0.93%) | (6.76%) | (6.30%) | (4.39%) | (6.59%) |
Revenue per Share |
1.47 | 1.38 | 0.56 | 0.46 | 0.37 | 0.46 | 0.37 | 0.33 | 0.32 | 0.36 |
Operating CF per Share |
(0.30) | (0.21) | (0.05) | (0.07) | (0.05) | (0.04) | (0.11) | (0.11) | (0.10) | (0.15) |
Capex per Share |
(0.02) | 0.00 | (0.01) | 0.00 | 0.00 | (0.02) | (0.03) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.32) | (0.21) | (0.05) | (0.07) | (0.05) | (0.06) | (0.14) | (0.12) | (0.10) | (0.15) |
Cash per Share |
0.39 | 0.16 | 0.21 | 0.48 | 0.61 | 0.52 | 0.38 | 0.25 | 0.15 | 0.15 |
Shareholders Equity per Share |
(0.71) | (0.91) | 0.14 | 0.45 | 0.55 | 0.52 | 0.42 | 0.27 | 0.13 | 0.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.71) | (0.91) | 0.14 | 0.45 | 0.55 | 0.52 | 0.42 | 0.27 | 0.13 | 0.21 |
Free Cash Flow |
(6.97) | (4.76) | (2.81) | (4.65) | (3.58) | (4.34) | (10.79) | (9.50) | (8.53) | (13.78) |
Working Capital |
(16.25) | (20.26) | 7.78 | 26.67 | 39.14 | 38.13 | 28.96 | 20.02 | 4.84 | 11.49 |
Capital Expenditures |
(0.41) | (0.08) | (0.27) | (0.03) | (0.07) | (1.40) | (2.38) | (0.37) | (0.03) | (0.09) |
Net Current Asset Value |
(17.09) | (21.40) | 6.73 | 23.77 | 37.49 | 29.83 | 21.76 | 13.28 | (8.85) | 0.32 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.04 | 0.08 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.70 | 1.44 | 1.76 | 0.49 | 0.65 | 0.04 | 0.08 | 0.09 | 0.27 | 0.52 |
Cash ROIC |
99.22% | 28.11% | (15.56%) | (7.64%) | (4.20%) | (5.52%) | (17.73%) | (22.49%) | (35.74%) | (42.87%) |
Accounts Receivable Turnover |
5.83 | 6.96 | 6.31 | 5.58 | 6.02 | 7.85 | 5.36 | 6.01 | 7.04 | 4.63 |
Accounts Payable Turnover |
3.37 | 5.03 | 3.38 | 3.21 | 4.13 | 4.07 | 2.59 | 3.69 | 2.78 | 2.93 |
Inventory Turnover |
1.52 | 3.29 | 4.89 | 4.04 | 2.98 | 3.05 | 1.57 | 1.46 | 1.47 | 1.71 |
Average Days of Payables |
127.16 | 56.14 | 110.22 | 124.85 | 76.61 | 129.70 | 123.34 | 97.75 | 167.87 | 113.70 |
Days of Inventory on Hand |
260.86 | 38.93 | 76.08 | 109.89 | 156.95 | 137.25 | 297.07 | 258.21 | 246.74 | 228.14 |
Average Receivables |
5.52 | 4.48 | 4.65 | 5.18 | 4.42 | 4.46 | 5.25 | 4.46 | 3.82 | 6.99 |
Average Payables |
2.23 | 2.14 | 1.69 | 1.91 | 1.85 | 2.90 | 3.73 | 3.23 | 4.43 | 5.22 |
Average Inventory |
4.94 | 3.26 | 1.17 | 1.52 | 2.57 | 3.86 | 6.15 | 8.15 | 8.38 | 8.95 |
Average Assets |
19.92 | 15.82 | 14.59 | 31.05 | 49.52 | 58.22 | 57.20 | 47.66 | 44.32 | 49.49 |
Average Common Equity |
(19.56) | (24.03) | (12.63) | 12.04 | 28.69 | 34.23 | 30.09 | 21.34 | 11.21 | 9.78 |
Columns are period end dates